HITECK

Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the production and sales of bioengineering products and lyophilized powder injections in China and internationally. The company operates through Biopharmaceutical Division; Pharmaceutical Technology Services Division; In Vitro Diagnostic Reagents Division; Production and Sales Division of Active Pharmaceutical Ingredients and Pharmaceutical Intermediates; and Other Divisions segments. Its products include Epramine for injection; mouse nerve growth factor for injection; omeprazole sodium for injection, an alternative therapy for duodenal ulcer, gastric ulcer, reflux esophagitis; tinidazole suppository, acyclovir dispersible tablets, nimodipine extended-release tablets, trimetazidine hydrochloride tablets, azithromycin granules, esomeprazole sodium for injection, and cyclic adenosine monophosphate for injection; Pentoxone theobromine injection; Roxatidine Acetate Hydrochloride for Injection; and Terizazole phosphate for injection. The company also provides measles and rubella virus nucleic acid detection kits; isolation and identification tubes and kits for mycoplasma; and bacterial vaginosis (BV) rapid test kits, as well as diagnostic kits for novel coronavirus N-Protein, as well as raw materials and intermediates.